These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1573635)

  • 1. Anthracene-9,10-diones as potential anticancer agents. Synthesis, DNA-binding, and biological studies on a series of 2,6-disubstituted derivatives.
    Agbandje M; Jenkins TC; McKenna R; Reszka AP; Neidle S
    J Med Chem; 1992 Apr; 35(8):1418-29. PubMed ID: 1573635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, molecular modeling, DNA binding, and antitumor properties of some substituted amidoanthraquinones.
    Collier DA; Neidle S
    J Med Chem; 1988 Apr; 31(4):847-57. PubMed ID: 3351863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.
    Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C
    J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
    Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
    J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antineoplastic evaluation of 1,4-bis(aminoalkanamido)-9,10-anthracenediones.
    Martelli S; Dzieduszycka M; Stefanska B; Bontemps-Gracz M; Borowski E
    J Med Chem; 1988 Oct; 31(10):1956-9. PubMed ID: 3172129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(1 -hydroxyiminoalkyl)-1 ,4-dimethoxy-9,10-anthraquinones: synthesis and evaluation of cytotoxicity.
    Tam MN; Nam NH; Jin GZ; Ahn BZ
    Arch Pharm Res; 2000 Aug; 23(4):283-7. PubMed ID: 10976572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
    Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
    J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity.
    Zee-Cheng RK; Podrebarac EG; Menon CS; Cheng CC
    J Med Chem; 1979 May; 22(5):501-5. PubMed ID: 458801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and calculated properties of some 1,4-bis(amino)anthracene-9,10-diones.
    Morley JO; Furlong PJ
    Org Biomol Chem; 2006 Nov; 4(21):4005-14. PubMed ID: 17047882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, DNA binding, topoisomerase II inhibition and cytotoxicity of two guanidine-containing anthracene-9,10-diones.
    Routier S; Bernier JL; Catteau JP; Riou JF; Bailly C
    Anticancer Drug Des; 1998 Jul; 13(5):407-15. PubMed ID: 9702207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclopent[a]anthraquinones as DNA intercalating agents with covalent bond formation potential: synthesis and biological activity.
    Kim JY; Su TL; Chou TC; Koehler B; Scarborough A; Ouerfelli O; Watanabe KA
    J Med Chem; 1996 Jul; 39(14):2812-8. PubMed ID: 8709111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituent position dictates the intercalative DNA-binding mode for anthracene-9,10-dione antitumor drugs.
    Tanious FA; Jenkins TC; Neidle S; Wilson WD
    Biochemistry; 1992 Nov; 31(46):11632-40. PubMed ID: 1445899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems.
    Krapcho AP; Landi JJ; Shaw KJ; Phinney DG; Hacker MP; McCormack JJ
    J Med Chem; 1986 Aug; 29(8):1370-3. PubMed ID: 3735305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.
    Zee-Cheng RK; Cheng CC
    J Pharm Sci; 1982 Jun; 71(6):708-9. PubMed ID: 7097541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterosubstituted anthracene-9,10-dione analogues. The synthesis and antitumor evaluation of 5,8-bis[(aminoalkyl)amino]naphtho[2,3-b] thiophene-4,9-diones.
    Krapcho AP; Petry ME; Hacker MP
    J Med Chem; 1990 Sep; 33(9):2651-5. PubMed ID: 2391703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
    Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
    Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
    Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxoisoaporphine alkaloid derivatives: synthesis, DNA binding affinity and cytotoxicity.
    Tang H; Wang XD; Wei YB; Huang SL; Huang ZS; Tan JH; An LK; Wu JY; Chan AS; Gu LQ
    Eur J Med Chem; 2008 May; 43(5):973-80. PubMed ID: 17720282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents.
    Zagotto G; Supino R; Favini E; Moro S; Palumbo M
    Farmaco; 2000 Jan; 55(1):1-5. PubMed ID: 10755224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-antitumor activity relationships among quinone derivatives.
    Driscoll JS; Hazard GF; Wood HB; Goldin A
    Cancer Chemother Rep 2; 1974 Apr; 4(2):1-362. PubMed ID: 4856629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.